ArticleFrontiers in public health2025
Evaluating the quality and reliability of Kawasaki disease-related content on TikTok and Bilibili: a cross-sectional study.
Article in Frontiers in public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Quality, interaction, and platform-creator heterogeneity of DR short videos on Douyin and Bilibili: a cross-sectional study.Scientific reports · 2026Article
- Content Quality, Reliability, and Factors Associated With Likes of Venous Thromboembolism-Related Short Videos on TikTok and Bilibili: A Cross-Platform Analysis.Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/HemostasisArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: As public interest in health and immunology grows, short video platforms have become an increasingly important source of medical information. Kawasaki disease, a pediatric immune-mediated vasculitis with potential cardiovascular complications, has attracted substantial attention; however, the accuracy and quality of related content on these platforms remain unexamined. This study aimed to evaluate the overall quality of Kawasaki disease-related videos on TikTok and Bilibili. Method: On February 25, 2025, newly registered accounts were used to search the term "" (Kawasaki disease) on TikTok and Bilibili, and the top 100 videos from each platform were collected. Video quality was evaluated using the JAMA benchmark criteria, a modified DISCERN, and PEMAT, while user engagement metrics (likes, comments, saves, and shares) were analyzed for correlations. Results: A total of 146 videos were included. Although TikTok videos demonstrated higher quality and popularity than those on Bilibili, overall video quality on both platforms remained suboptimal. Median JAMA scores were 2.00 and 1.00, modified DISCERN scores were both 3.00, intelligibility was 70% versus 64%, and operability was 67% on both platforms. Most videos were monologue-based and symptom-focused, with pediatricians and individual users as the main uploaders. Pediatricians and individual users were the two largest groups of content creators. Pediatrician-uploaded videos showed higher quality and engagement, whereas individual-user videos were more often misleading and less interactive. Five major misinformation themes were identified, including symptom oversimplification, incorrect etiological claims, promotion of non-evidence-based home treatments, misunderstanding of diagnostic criteria, and misleading statements about immunoglobulin therapy. Video quality was positively correlated with popularity, while longer duration was negatively associated with both quality and engagement. Heterogeneity was observed across platforms. Conclusion: The quality and reliability of Kawasaki disease-related videos on short video platforms remain suboptimal, highlighting the need to address misinformation, refine evaluation tools, and promote high-quality content creation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.